We describe a procedure for enzymatic assay of citrate in human serum. The citrate is degraded to acetate and oxaloacetate with citrate oxaloacetate.-lyase (pro-3 S-CH2 . COO -k acetate) (EC 4.1.3.6). Some oxaloacetate loses CO2 to form pyruvate. Addition of malate and lactate dehydrogenases (EC 1.1.1.37 and 1.1.1.27) permits determination .of the oxaloacetate and pyruvate generated, and thus of the citrate concentration. The decrease in NADH concentration is measured fluorometrically. Results obtained for 30 consecutive human sera by this procedure were compared to the procedure in which the citrate is converted to pentabromoacetone. There was no statistically significant difference in values obtained by the two procedures. The range of values (mean ±2 SD) found for sera from 25 blood donors by this procedure was 12.8-27.2 mg/liter (mean, 19 .0 mg/liter). Serum citrate as measured by both procedures during a glucose tolerance test was decreased from initial values under the influence of administered glucose (and endogenous insulin). Insulin concentrations were also measured during these glucose-tolerance tests. Citrate concentrations remain subnormal after the glucose and insulin concentrations return to their initial values. This accords with published reports. (6) , with a notable exception when corticotropin, administered intramuscularly to certain animals such as the rabbit, markedly decreases calcium and increases citrate concentration (7) . The mechanism involved in these phenomena perhaps has some significance in the origin of convulsive seizures in the human (1, 8) .
After a test substance is administered, the significance of citrate concentration in serum is not apparent unless sequential analyses are done and unless each value represents the results of two or more determinations.
Experimentation in this direction has been hindered by the fact that present methods require substantial amounts of serum for the analysis. This limits the use of smaller animals in such experiments.
Enzymatic procedures for citrate determination in the past have not been reproducible because of the difficulty in obtaining pure enzyme preparations (9) (10) (11) We decided to see whether the procedure could be modified so as to be applied to smaller quantities of human serum, by measuring the NADH fluorometrically. We also studied experimental conditions, to improve reliability and sensitivity.
We compared results obtained by this procedure with those obtained by converting the citrate to pentabromoacetone (13) . In spite of the laborious protocol with the pentabromoacetone procedure, the method has been widely used because of its specificity and reproducibility (13, 14) .
The enzymatic procedure being investigated was applied to plasma and serum of patients who were undergoing a glucose-tolerance test. We analyzed for citrate in the specimens from these patients by both the enzymatic and the pentabromoacetone.
procedure. At the same time, we assayed for insulin concentration. Our objective was to see whether the new procedure would show the decreased citrate concentrations that occur (2, 14) during a glucose-tolerance test. On the day of the test, mix 9.4 ml of the buffer, 0.2 ml of the zinc chloride, 0.2 ml of the NADH solution, 0.2 ml of the malate dehydrogenase solution, and 0.2 ml of the lactate dehydrogenase solution. Refrigerated (4 #{176}C), this mixture is stable for 48 h. 
Materials and Methods

Instrumentation
Results
Standard curves were linear through a concentration of 40 mg/liter, with only a slight downward curvature at 60 mg/liter. Because the results were read directly from the curve, this was taken into account in calculating the final result. Because we intended to apply this procedure to specimens taken during a glucose-tolerance test, it was necessary to see whether glucose and other substances normally present in serum interfere. When glucose was added to the solution to give concentrations as great as 300 mg/100 ml, interference in the lyase procedure was + 1.6%. Acetoacetate produced a slight decrease in the value expected (-1.9%).
Nei-'ther of these interferences was significant (t-test).
However, when a-ketoglutarate was added to increase its concentration to 100 mg/100 ml, there was an interference of +8.6%, which was statistically significant.
Fortunately, this is at least 50-fold the normal concentration of this substance in serum and manyfold the concentrations found in sera of uncontrolled diabetics. Figure 1 shows the correlation between the two procedures under study. The correlation coefficient the course of oxidation of the NADH. In exploring this procedure, which had been reported (12) , we found that at the pH at which the reaction was being carried out, the NADH was unstable and apparently was being degraded nonenzymatically, independent of the lyase reaction. We therefore studied conditions for stabilizing the NADH and found that the reaction is best carried out at a more alkaline pH.
The optimum pH for lyase activity, studied by measuring initial reaction velocity, was found to be pH 9.0, but at the more alkaline pH values, the enzyme was inactivated and the reaction did not go to completion. At the pH of 8.2 chosen, reaction velocity was satisfactory and the reaction went to completion. Table 1 indicates that for practical purposes, results by the enzymatic procedure correlate with those obtained by the pentabromoacetone procedure. The reproducibility of both procedures is about the same, about ±5% (2 SD). This is supported by the correlation study as indicated in Figure 1 .
Interference from acetoacetate and glucose is negpyruvate + CO2
ligible. ct-Ketoglutarate interferes because lactate dehydrogenase is not specific for pyruvate, there being some cross reaction with a-ketoglutarate, resulting in the utilization of NADH (18) . However, this is a rela- for glucose by the ferricyanide procedure with the AutoAnalyzer.
Discussion
The principle of the proposed procedure is that this citrate lyase mediates the decomposition of citrate to acetate and oxaloacetate.
In this reaction, zinc is used as a cofactor instead of the natural magnesium, because at the alkaline pH zinc increases the stability of the enzyme system (16 
+2
Zn tively slow reaction and at the concentration at which a-ketoglutarate occurs in serum this may also be ignored. Isocitrate and cis-aconitate cause no interference (12) .
Analysis of blood from 31 normal blood donors gave a mean value of 19.0 mg of citrate per liter, with a range (2 SD) of 15.4 to 22.6 mg/liter-not a broad range, considering the errors introduced in the procedure and the instability of citrate in drawn blood unless it is refrigerated promptly (19) . By the pentabromoacetone method, mean values for serum from normal adults of 21.4 and 24.2 mg/liter have been reported in earlier studies (1, 2, 14) . but soon declines, and is still low at the end of 3 h, long after the insulin and glucose concentrations have returned to normal. As with glucose or insulin, citrate concentrations return to initial values after about 5 h (2) . The initial increase in citrate concentration in these patients may be an effect of epinephrine, owing to the stress at the initiation of the tests. In any case, Figures 2, 3 , and 4 demonstrate that the enzymatic procedure can be used to follow citrate concentrations during a glucose-tolerance test. On the basis of the above studies, the relatively cumbersome pentabromoacetone procedure can be replaced with the procedure described here, which is simpler, less time consuming, more sensitive, and permits use of a smaller amount of serum.
Recently, a procedure has been reported by which the sensitivity of the pentabromoacetone method has been increased by assaying bromoform formed from pentabromoacetone after alkaline hydrolysis (20) . The enzymatic procedure is more rapid and convenient for the routine laboratory. 
